- Previous Rank486
- Revenues ($M)5,460
- Revenue Percent Change7.1%
- Profits ($M)356
- Profits Percent Change57.3%
- Market Value (as of March 31, 2015)8,358
The global contract-research firm conducts clinical trials and other activities for pharmaceutical companies.
Looking for leads, investment insights, or competitive intelligence?Buy Now
Company Info
| CEO | Thomas H. Pike |
| Industry | Health Care: Pharmacy and Other Services |
| Sector | Health Care |
| HQ Location | Durham, NC |
| Website | http://www.quintiles.com |
| Years on List | 2 |
Key Financials (last fiscal year)
| $ millions | % change | |
|---|---|---|
| Revenues ($M) | 5,460 | 7.1% |
| Profits ($M) | 356 | 57.3% |
| Total Stockholder Equity | -704 | - |
| Employees | 32,600 | - |
| Market Value (as of March 31, 2015) | 8,358 | - |
Profit Ratios
| Profit as % of Revenues | 6.5% |
| Profits as % of Assets | 10.8% |
| Profits as % of Stockholder Equity | - |
Earnings Per Share (last fiscal year)
| Earnings Per Share ($) | 2.72 |
| EPS % Change (from 2013) | 53.7% |
| EPS % Change (5 year annual rate) | - |
| EPS % Change (10 year annual rate) | - |
Total Return
| Total Return to Investors (2014) | 27% |
| Total Return to Investors (5 year, annualized) | - |
| Total Return to Investors (10 year, annualized) | - |
